# Tipifarnib Plus Trastuzumab in Treating Patients With Metastatic Breast Cancer

> **NCT00054470** · PHASE2 · WITHDRAWN · sponsor: **The University of Texas Health Science Center at San Antonio**

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** trastuzumab
- **DRUG:** tipifarnib

## Key facts

- **NCT ID:** NCT00054470
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2002-12
- **Primary completion:** 2003-01
- **Final completion:** 2003-01
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2012-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00054470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00054470, "Tipifarnib Plus Trastuzumab in Treating Patients With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00054470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*